[PHARMA] QoQ TTM Result on 30-Sep-2021 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Sep-2021 [#3]
Profit Trend
QoQ- 151.46%
YoY- 155.49%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 4,567,669 4,983,690 4,815,015 4,737,880 3,230,009 2,698,649 2,725,071 41.23%
PBT 265,267 282,990 277,075 138,481 44,355 36,437 35,793 281.51%
Tax -100,008 -104,757 -104,870 -58,488 -13,392 -9,755 -9,524 381.59%
NP 165,259 178,233 172,205 79,993 30,963 26,682 26,269 241.93%
-
NP to SH 163,766 176,748 172,150 80,344 31,951 28,226 27,489 229.70%
-
Tax Rate 37.70% 37.02% 37.85% 42.24% 30.19% 26.77% 26.61% -
Total Cost 4,402,410 4,805,457 4,642,810 4,657,887 3,199,046 2,671,967 2,698,802 38.69%
-
Net Worth 406,087 413,947 450,411 391,428 357,275 355,919 337,298 13.20%
Dividend
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Div 108,678 121,759 121,748 58,895 36,634 23,534 28,740 143.31%
Div Payout % 66.36% 68.89% 70.72% 73.30% 114.66% 83.38% 104.55% -
Equity
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Net Worth 406,087 413,947 450,411 391,428 357,275 355,919 337,298 13.20%
NOSH 1,309,126 1,309,126 1,309,126 1,309,126 261,991 261,705 261,705 193.35%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 3.62% 3.58% 3.58% 1.69% 0.96% 0.99% 0.96% -
ROE 40.33% 42.70% 38.22% 20.53% 8.94% 7.93% 8.15% -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 348.69 380.45 367.74 361.91 246.81 1,031.18 1,042.20 -51.90%
EPS 12.50 13.49 13.15 6.14 2.44 10.79 10.51 12.29%
DPS 8.30 9.30 9.30 4.50 2.80 9.00 11.00 -17.16%
NAPS 0.31 0.316 0.344 0.299 0.273 1.36 1.29 -61.44%
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 316.93 345.79 334.09 328.74 224.11 187.25 189.08 41.23%
EPS 11.36 12.26 11.94 5.57 2.22 1.96 1.91 229.34%
DPS 7.54 8.45 8.45 4.09 2.54 1.63 1.99 143.63%
NAPS 0.2818 0.2872 0.3125 0.2716 0.2479 0.247 0.234 13.23%
Price Multiplier on Financial Quarter End Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 -
Price 0.595 0.755 0.74 0.835 5.29 3.26 5.00 -
P/RPS 0.17 0.20 0.20 0.23 2.14 0.32 0.48 -50.03%
P/EPS 4.76 5.60 5.63 13.61 216.68 30.23 47.56 -78.53%
EY 21.01 17.87 17.77 7.35 0.46 3.31 2.10 366.26%
DY 13.95 12.32 12.57 5.39 0.53 2.76 2.20 243.74%
P/NAPS 1.92 2.39 2.15 2.79 19.38 2.40 3.88 -37.51%
Price Multiplier on Announcement Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 19/08/22 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 17/03/21 -
Price 0.595 0.72 0.76 0.845 0.925 4.03 3.49 -
P/RPS 0.17 0.19 0.21 0.23 0.37 0.39 0.33 -35.81%
P/EPS 4.76 5.34 5.78 13.77 37.89 37.37 33.20 -72.70%
EY 21.01 18.74 17.30 7.26 2.64 2.68 3.01 266.53%
DY 13.95 12.92 12.23 5.32 3.03 2.23 3.15 170.41%
P/NAPS 1.92 2.28 2.21 2.83 3.39 2.96 2.71 -20.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment